Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Biotechnology

Education

Shoreline Biosciences

Kleanthis G. Xanthopoulos

Krishna Patel

Mauro P. Avanzi

Paschalis Sideras

Charles Calderaro III

Robert Hollingsworth

Scott Forrest

Steven Neben

Vanessa Jacoby

The Advisory Team at Shoreline Biosciences provides strategic guidance and expertise to enhance the development and implementation of the company's proprietary cell therapy technology. Comprised of seasoned professionals, including the co-founder and chair of the Scientific Advisory Board (SAB), the team advises on scientific, clinical, and commercial aspects to optimize the metabolic fitness and anti-cancer efficacy of engineered NK Cells.

Advisory Team

Scientific Research

Leadership Team

Advisory Team

About

Team members

Other teams at Shoreline Biosciences

Scientific Research

Leadership Team